Elicio Therapeutics (ELTX) Amortizatization of Intangibles (2020 - 2026)
Elicio Therapeutics posted quarterly Amortizatization of Intangibles of $243000.0 for Q1 2026, up 8.0% year-on-year from $225000.0 in Q1 2025, and up 2.53% on a QoQ basis from $237000.0 in Q4 2025.
Elicio Therapeutics (ELTX) has 7 years of Amortizatization of Intangibles data on file, last reported at $243000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 8.0% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 456.27% YoY), and the FY2025 full-year result was $924000.0, up 1132.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $243000.0, up from $237000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $400000.0 in Q3 2025 and bottomed at -$562000.0 in Q4 2024.
- The 5-year median for Amortizatization of Intangibles is $201000.0 (2022), against an average of $160857.1.
- The widest annual swing landed in 2024, when Amortizatization of Intangibles plunged 372.82%; it then soared 1438.46% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $194000.0 in 2022, then advanced by 6.19% to $206000.0 in 2023, then slumped by 372.82% to -$562000.0 in 2024, then soared by 142.17% to $237000.0 in 2025, then advanced by 2.53% to $243000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $243000.0 (Q1 2026), $237000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,000.00 |
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Dec 31, 2025 | 237,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 228,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Dec 31, 2024 | -562,000.00 |
| Dec 31, 2024 | -562,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 185,000.00 |
| Sep 30, 2023 | 185,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Jun 30, 2023 | 397,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Dec 31, 2022 | 194,000.00 |
| Sep 30, 2022 | 190,000.00 |
| Sep 30, 2022 | 190,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 196,000.00 |
| Mar 31, 2022 | 196,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 187,000.00 |
| Sep 30, 2021 | 187,000.00 |
| Jun 30, 2021 | 183,000.00 |
| Jun 30, 2021 | 183,000.00 |
| Mar 31, 2021 | 149,000.00 |
| Mar 31, 2021 | 149,000.00 |
| Dec 31, 2020 | 134,000.00 |
| Dec 31, 2020 | 134,000.00 |
| Sep 30, 2020 | 129,000.00 |
| Sep 30, 2020 | 129,000.00 |
| Jun 30, 2020 | 123,000.00 |
| Jun 30, 2020 | 123,000.00 |
| Mar 31, 2020 | 144,000.00 |
| Mar 31, 2020 | 144,000.00 |